Clinical Trial Update: Treatment for HBV-MN Patients in Chinese: An Open Parallel Controlled Trial

View source ↗

Summary

An open parallel-controlled clinical trial in Chinese patients with hepatitis B virus-associated membranous nephropathy evaluating a treatment for HBV-MN. The c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis Virus-associated Membranous Nephropathy

Snippet

Sponsor: Nanchang University | Conditions: Proteinuria, HBVe-antigen | Status: UNKNOWN